{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:31:04Z","timestamp":1789205464947,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T00:00:00Z","timestamp":1367107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00125-013-2922-0","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T16:27:29Z","timestamp":1367425649000},"page":"1680-1688","source":"Crossref","is-referenced-by-count":71,"title":["Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)"],"prefix":"10.1007","volume":"56","author":[{"given":"W. E.","family":"Boertien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. J.","family":"Riphagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Drion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alkhalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Groenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. E.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J. G.","family":"Bilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kleefstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,28]]},"reference":[{"key":"2922_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/jcem-42-4-613","volume":"42","author":"GL Robertson","year":"1976","unstructured":"Robertson GL, Athar S (1976) The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 42:613\u2013620","journal-title":"J Clin Endocrinol Metab"},{"key":"2922_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1043-2760(00)00304-0","volume":"11","author":"M Birnbaumer","year":"2000","unstructured":"Birnbaumer M (2000) Vasopressin receptors. Trends Endocrinol Metab 11:406\u2013410","journal-title":"Trends Endocrinol Metab"},{"key":"2922_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ki.1995.2","volume":"47","author":"L Bankir","year":"1995","unstructured":"Bankir L, Kriz W (1995) Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and CRF. Kidney Int 47:7\u201324","journal-title":"Kidney Int"},{"key":"2922_CR4","first-page":"F819","volume":"246","author":"M Gellai","year":"1984","unstructured":"Gellai M, Silverstein JH, Hwang JC, LaRochelle FT Jr, Valtin H (1984) Influence of vasopressin on renal hemodynamics in conscious brattleboro rats. Am J Physiol 246:F819\u2013F827","journal-title":"Am J Physiol"},{"key":"2922_CR5","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.96.18.10397","volume":"96","author":"P Bardoux","year":"1999","unstructured":"Bardoux P, Martin H, Ahloulay M et al (1999) Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient brattleboro rats. Proc Natl Acad Sci USA 96:10397\u201310402","journal-title":"Proc Natl Acad Sci USA"},{"key":"2922_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000045879","volume":"87","author":"L Bankir","year":"2001","unstructured":"Bankir L, Bardoux P, Ahloulay M (2001) Vasopressin and diabetes mellitus. Nephron 87:8\u201318","journal-title":"Nephron"},{"key":"2922_CR7","first-page":"F973","volume":"258","author":"N Bouby","year":"1990","unstructured":"Bouby N, Bachmann S, Bichet D, Bankir L (1990) Effect of water intake on the progression of chronic renal failure in the 5\/6 nephrectomized rat. Am J Physiol 258:F973\u2013F979","journal-title":"Am J Physiol"},{"key":"2922_CR8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diabetes.28.5.503","volume":"28","author":"RL Zerbe","year":"1979","unstructured":"Zerbe RL, Vinicor F, Robertson GL (1979) Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503\u2013508","journal-title":"Diabetes"},{"key":"2922_CR9","first-page":"73","volume":"20","author":"G Tallroth","year":"1992","unstructured":"Tallroth G, Ryding E, Ekman R, Agardh CD (1992) The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetes Res 20:73\u201385","journal-title":"Diabetes Res"},{"key":"2922_CR10","first-page":"875","volume":"46","author":"T Nishikawa","year":"1996","unstructured":"Nishikawa T, Omura M, Iizuka T, Saito I, Yoshida S (1996) Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus. Arzneimittelforschung 46:875\u2013878","journal-title":"Arzneimittelforschung"},{"key":"2922_CR11","doi-asserted-by":"crossref","unstructured":"Enh\u00f6rning S, Wang TJ, Nilsson PM et al (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102\u20132108","DOI":"10.1161\/CIRCULATIONAHA.109.909663"},{"key":"2922_CR12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00125-012-2545-x","volume":"55","author":"A Abbasi","year":"2012","unstructured":"Abbasi A, Corpeleijn E, Meijer E et al (2012) Sex differences in the association between plasma copeptin and incident type 2 diabetes: the prevention of renal and vascular endstage disease (PREVEND) study. Diabetologia 55:1963\u20131970","journal-title":"Diabetologia"},{"key":"2922_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/18.3.497","volume":"18","author":"P Bardoux","year":"2003","unstructured":"Bardoux P, Bichet DG, Martin H et al (2003) Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 18:497\u2013506","journal-title":"Nephrol Dial Transplant"},{"key":"2922_CR14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/A:1025369623365","volume":"18","author":"LJ Ubink-Veltmaat","year":"2003","unstructured":"Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B (2003) Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol 18:793\u2013800","journal-title":"Eur J Epidemiol"},{"key":"2922_CR15","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","volume":"5","author":"JJ Preibisz","year":"1983","unstructured":"Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB (1983) Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5:I129\u2013I138","journal-title":"Hypertension"},{"key":"2922_CR16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","volume":"52","author":"GL Robertson","year":"1973","unstructured":"Robertson GL, Mahr EA, Athar S, Sinha T (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52:2340\u20132352","journal-title":"J Clin Invest"},{"key":"2922_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112\u2013119","journal-title":"Clin Chem"},{"key":"2922_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","volume":"19","author":"NG Morgenthaler","year":"2008","unstructured":"Morgenthaler NG, Struck J, Jochberger S, Dunser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43\u201349","journal-title":"Trends Endocrinol Metab"},{"key":"2922_CR19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","volume":"94","author":"W Fenske","year":"2009","unstructured":"Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B (2009) Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 94:123\u2013129","journal-title":"J Clin Endocrinol Metab"},{"key":"2922_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"2922_CR21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"2922_CR22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","volume":"34","author":"E Ritz","year":"1999","unstructured":"Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795\u2013808","journal-title":"Am J Kidney Dis"},{"key":"2922_CR23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","volume":"37","author":"S Enh\u00f6rning","year":"2013","unstructured":"Enh\u00f6rning S, Bankir L, Bouby N et al (2013) Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective malmo diet and cancer study cardiovascular cohort. Int J Obes (Lond) 37:598\u2013603","journal-title":"Int J Obes (Lond)"},{"key":"2922_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","volume":"77","author":"E Meijer","year":"2010","unstructured":"Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT (2010) Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 77:29\u201336","journal-title":"Kidney Int"},{"key":"2922_CR25","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1093\/ndt\/gfs070","volume":"27","author":"WE Boertien","year":"2012","unstructured":"Boertien WE, Meijer E, Zittema D et al (2012) Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 27:4131\u20134137","journal-title":"Nephrol Dial Transplant"},{"key":"2922_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/TP.0b013e3181b11ae4","volume":"88","author":"E Meijer","year":"2009","unstructured":"Meijer E, Bakker SJ, de Jong PE et al (2009) Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation 88:561\u2013567","journal-title":"Transplantation"},{"key":"2922_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/diacare.18.4.572","volume":"18","author":"CE Mogensen","year":"1995","unstructured":"Mogensen CE, Vestbo E, Poulsen PL et al (1995) Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 18:572\u2013581","journal-title":"Diabetes Care"},{"key":"2922_CR28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1681\/ASN.2010070691","volume":"22","author":"W Fenske","year":"2011","unstructured":"Fenske W, Wanner C, Allolio B et al (2011) Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. J Am Soc Nephrol 22:782\u2013790","journal-title":"J Am Soc Nephrol"},{"key":"2922_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000326902","volume":"34","author":"E Meijer","year":"2011","unstructured":"Meijer E, Boertien WE, Zietse R, Gansevoort RT (2011) Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease. Kidney Blood Press Res 34:235\u2013244","journal-title":"Kidney Blood Press Res"},{"key":"2922_CR30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MNH.0b013e32833d35cf","volume":"19","author":"D Bolignano","year":"2010","unstructured":"Bolignano D, Zoccali C (2010) Vasopressin beyond water: implications for renal diseases. Curr Opin Nephrol Hypertens 19:499\u2013504","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2922_CR31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1962.03620230204028","volume":"110","author":"DL Singer","year":"1962","unstructured":"Singer DL, Drolette ME, Hurwitz D, Freinkel N (1962) Serum osmolality and glucose in maturity onset diabetes mellitus. Arch Intern Med 110:758\u2013762","journal-title":"Arch Intern Med"},{"key":"2922_CR32","first-page":"37","volume":"14","author":"A Grimaldi","year":"1988","unstructured":"Grimaldi A, Pruszczynski W, Jacquin V, Thervet F, Ardaillou R (1988) Vasopressin secretion during hyperglycemia in insulin-dependent diabetics. Diabete Metab 14:37\u201339","journal-title":"Diabete Metab"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-2922-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2922-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:48Z","timestamp":1558597788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-2922-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,28]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2922"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-2922-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,28]]}}}